Rigel Pharmaceuticals logo
Rigel Pharmaceuticals RIGL
€ 16.44 -0.9%

Quartalsbericht 2024-Q3
hinzugefügt 07.11.2024

report update icon

Rigel Pharmaceuticals Kennzahlen 2011-2024 | RIGL

Kennzahlen Jährlich Rigel Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-10.3 -4.4 -24.4 -20.7 -5.9 -4.9 -6.5 -2.8 -4.7 -2.0 -3.1 -4.8 -7.2

P/S

2.2 2.1 2.9 5.7 6.6 7.8 112.4 9.6 8.4 22.0 38.5 212.9 129.5

EPS

-0.1 -0.3 -0.1 -0.2 -0.4 -0.4 -0.6 -0.7 -0.6 -1.0 -1.0 -1.3 -1.4

EV (Enterprise Value)

372 M 379 M 555 M 660 M 463 M 301 M 484 M 202 M 240 M 192 M 272 M 467 M 617 M

EBITDA per Share

-0.11 -0.32 -0.07 -0.17 -0.409 -0.449 -0.627 -0.668 -0.569 -1.01 -0.976 -1.29 -1.33

EV/EBITDA

-28.4 -21.4 -5.5 -3.8 -5.9 -2.8 -4.0 -1.9 -3.0 -4.6 -7.1

PEG

-0.31 -0.11 0.76 1.22 -0.64 -0.17 -0.43 0.11 -0.11 1.02 -0.14 -1.65 0.02

P/B

-9.1 -18.7 14.4 18.1 7.3 3.2 5.0 3.6 2.7 1.4 1.3 1.7 2.6

P/CF

-45.1 -3.5 74.3 -11.8 -9.1 -5.8 -6.5 -2.6 -10.2 -2.6 -3.2 -5.4 -8.6

ROE %

87.60 430.18 -58.98 -87.42 -124.30 -64.14 -77.49 -125.79 -56.32 -70.89 -42.75 -34.19 -36.41

ROA %

-21.40 -43.62 -10.71 -26.95 -45.33 -50.67 -65.48 -88.59 -39.06 -58.98 -39.38 -31.88 -33.44

ROCE %

71.54 407.98 -41.14 -85.15 -77.32 -65.26 -79.00 -115.17 -52.83 -65.13 -40.69 -33.37 -35.17

Current Ratio

0.8 0.9 1.2 1.4 2.0 4.9 6.4 3.4 3.8 10.7 21.4 24.8 21.7

DSO

110.7 84.7 38.5 43.8 62.2 33.4 - - 2.6 254.4 293.5 - -

DIO

375.8 1641.8 1390.9 610.1 545.5 1137.0 - - - - - - -

DPO

761.1 2744.6 1264.2 1602.5 1672.7 8127.9 - - - - - - -

Betriebszyklus

486.4 1726.5 1429.4 653.9 607.7 1170.4 - - - - - - -

Finanzkreislauf

-274.6 -1018.1 165.2 -948.6 -1065.0 -6957.5 - - - - - - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Rigel Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.71 -0.06 -0.05 -0.33 -0.38 -0.08 - -0.11 -0.08 -0.16 - -0.12 -0.08 0.23 -0.11 -0.08 -0.1 0.13 -0.1 -0.07 -0.12 -0.11 0.02 -0.14 -0.16 -0.17 -0.18 -0.14 -0.16 -0.13 -0.16 -0.24 -0.15 -0.19 -0.14 -0.08 -0.16 -0.21 -0.25 -0.24 -0.29 -0.25 -0.19 -0.27 -0.26 -0.29 -0.3 -0.36 -0.35 -0.32 -0.36 -0.25 -0.37 -0.4

EBITDA per Share

0.83 0.06 -0.04 -0.24 -0.29 -0.07 - -0.1 -0.08 -0.15 - -0.11 -0.08 0.25 - -0.08 -0.1 0.13 - -0.07 -0.13 -0.11 - -0.14 -0.16 -0.17 - -0.14 -0.16 -0.14 - -0.23 -0.14 -0.19 - -0.06 -0.15 -0.2 - -0.22 -0.28 -0.25 - -0.25 -0.25 -0.29 - -0.33 -0.33 -0.32 - -0.23 -0.35 -0.39

ROE %

-37.50 70.84 123.20 193.14 271.24 614.70 59.19 17.01 -121.16 -508.38 -12.03 -68.56 -68.04 -36.97 -24.98 -0.41 -51.09 -132.86 -228.00 -193.10 -167.84 -142.30 -131.79 -160.43 -145.14 -133.92 -126.95 -129.57 -175.24 -197.33 -213.85 -199.41 -109.25 -68.15 -56.32 -59.80 -68.83 -73.40 -70.89 -61.62 -56.73 -47.86 -42.75 -43.46 -40.83 -38.45 -34.19 -36.30 -35.09 -35.62 -36.41 -7.59 -9.09 -8.80

ROA %

-3.35 -17.89 -28.04 -37.99 -49.52 -62.29 -53.29 -64.52 -40.88 -47.73 0.20 -17.23 -18.84 -8.66 -7.70 -1.93 -22.76 -51.97 -83.14 -69.17 -88.48 -98.49 -104.10 -128.14 -118.91 -111.94 -107.27 -105.50 -130.38 -141.11 -150.61 -140.29 -76.72 -47.61 -39.06 -43.88 -52.41 -58.32 -58.98 -51.99 -48.94 -42.54 -39.38 -40.14 -37.81 -35.72 -31.88 -33.69 -32.46 -32.83 -33.44 -6.97 -8.35 -8.08

ROCE %

-61.51 53.26 107.21 178.00 256.76 590.63 59.08 19.24 -113.37 -485.13 -5.66 -46.16 -46.83 -78.79 -29.82 -52.19 -34.05 -22.59 -96.17 -118.35 -118.16 -102.27 -68.45 -86.19 -81.76 -77.21 -53.06 -94.38 -117.96 -123.55 -98.05 -105.47 -71.57 -62.06 -42.67 -59.08 -68.07 -72.62 -53.71 -65.20 -60.29 -51.43 -34.83 -43.67 -41.02 -38.64 -25.51 -33.15 -31.95 -32.47 -25.60 -7.64 -9.13 -8.83

Current Ratio

0.9 0.8 0.8 0.8 0.8 0.8 0.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

49.1 69.9 78.9 72.0 85.2 122.0 - 31.6 23.3 83.7 - 68.5 277.2 89.1 79.0 79.3 91.0 21.3 59.9 44.2 88.7 51.3 9.8 76.5 208.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

73.0 237.9 285.9 607.9 927.7 943.1 - 1298.7 297.9 5045.1 - 4190.2 4873.7 1239.5 - 1067.6 535.7 880.7 - 398.6 397.3 958.5 - 1182.3 2719.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

56.5 250.4 389.2 476.4 489.6 1345.1 - 496.6 203.2 3170.8 - 1460.3 2399.4 1270.9 - 2416.2 1212.4 2313.3 - 1222.2 1218.2 4495.6 - 8451.9 19439.3 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

122.1 307.8 364.8 679.8 1012.9 1065.0 - 1330.3 321.2 5128.9 - 4258.8 5150.9 1328.6 79.0 1146.9 626.7 902.0 59.9 442.8 485.9 1009.8 9.8 1258.8 2927.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Finanzkreislauf

65.5 57.4 -24.4 203.5 523.3 -280.0 - 833.7 118.0 1958.1 - 2798.5 2751.5 57.7 79.0 -1269.3 -585.7 -1411.3 59.9 -779.4 -732.3 -3485.7 9.8 -7193.1 -16511.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung